Malignant peripheral nerve sheath tumours (MPNSTs) commonly occur in patients with neurofibromatosis type 1 (NF1). To identify potential molecular drivers, Mo et al. analysed the gene expression signatures in MPNSTs that arose in Nf1-deficient mice. They found upregulation of CXCR4, which is a receptor for the CXCL12 chemokine. Similar signalling alterations were also found in human NF1-deficient MPNSTs. Crucially, knockdown or small-molecule inhibition of CXCR4 slowed the growth of MPNSTs in mice, highlighting the potential value of CXCR4 as a therapeutic target.